R
Relmada Therapeutics (RLMD)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Relmada Therapeutics (RLMD)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... Read more
- USD0.63
- USD0.67
- USD0.62
- USD4.47
- -20.00%
- --
- 183.99k
- 661.52k
- 20M
- 0.24
- -80.00%
Stock News
yesterday
An upgrade for Apple’s stock? It’s not the endorsement you might think.
MarketWatch
yesterday
Jim Cramer explains how Microsoft, Meta and Nvidia led the Mag 7 pack in the first half of 2025
CNBC
yesterday
Bank of America Comments on Stress Test Results; Plans to Increase Quarterly Dividend 8% to $0.28 Per Share
Yahoo
yesterday
Mark Zuckerberg's costly AI talent push has not cost Meta stock yet. Here's why
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
